Consultations on highly specialized medical treatments ongoing in Switzerland

24

Jun 2020

The Swiss cantons are required to jointly draw up a plan for the provision of highly specialized medical treatments (MHS). It is up to the MHS decision-making body (which is part of the Conference of Cantonal Health Directors)  to determine which areas of care can be considered highly specialized medicine. The MHS decision-making body also decides on matters of planning and allocation of this type of care. These decisions result in the list of hospitals with highly specialized medicine. The planning of highly specialized medical treatments at the national level aims to provide economical care, adapted to needs, and of high quality.

The following areas of care are being discussed to enter the MHS, until September 17, 2020:

  • Partial areas of deep rectal resections and complex bariatric surgery (hospitals can already apply to become eligible to deliver this type of MHS)
  • Complex gynecological tumors
  • Pediatric oncology
  • Highly specialized pediatrics and pediatric surgery
  • Complex neurosurgery and neuroradiology (hospitals can already apply to become eligible to deliver this type of MHS)

Outcomes of this consultation is expected in early 2021.

See more details in French (switch to German in the top-right corner) here. See all other areas of care that will be discussed later in the year (some topics were postponed due to the COVID19 crisis) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

18

Feb 2022

Dutch Organization for Health Research and Development, ZonMw awarded eight projects under the "Healthcare Evaluation and Appropriate Use" program, including two projects for geriatric care, two projects for cancer, per one project for cardiovascular, neurovascular, and dermatology care.

Read more

14

Feb 2022

On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.

Read more

10

Jan 2022

On December 20, 2021, the tariff partners of the novel TARDOC reimbursement system for outpatient care (association of health insurers curafutura and association of physicians, FMH) re-submitted the substantially revised version 1.3 of TARDOC to the Federal Council. The tariff partners hope that the Federal Council will assess the new reimbursement system in the first quarter of 2022 and that it could be implemented from January 2023.

Read more

27

Dec 2021

On December 17, 2021, NHS Digital released HRG4+ Consultation Grouper for 2022/23. This release is used to support the NHS England and Improvement consultation process for the 2022/23 National Tariff Payment System. In general, there are significant changes in base HRG design. A total of 120 new HRGs were created, multiple HRGs were removed, and the grouping logic was updated significantly. This Consultation Grouper will be superseded by the 2022/23 Local Payment Grouper in March 2022, for use from April 01, 2022.

Read more